Susan Hasty, Publisher
Table of Contents . . . August 19th, 1996Non-Subscriber - Summaries Only
Immunology - One Percent of Caucasians Immune to HIV
Antisense Technology - Oligonucleotides May Treat Hair Growth, Acne and Male Pattern Baldness
Conference Coverage (Montreal) - Quest for Safe, Efficacious Blood Substitute Turns 40
Conference Coverage (Vancouver) - First Humans Receive Naked HIV DNA Vaccine
HIV Gene Therapy - Ribozyme-Based Gene Therapy Reaches Clinical Trial Stage
HIV Gene Therapy - Vector Design Affects Protection Conferred by Antisense RNA Therapy
Industry News (Diagnostics) - Products Introduced for Use in Genetic Analysis
Malaria Gene Therapy - Identified Sequence Should Help in Constructing Plasmid Vectors
Mucosal Immunization - Bioengineered Bordetella pertussis Used for Intranasal Immunization
Non-Small Cell Lung Cancer (Therapy) - p53 Expression in NSCLC Predicts Response To Therapy
Pathogenesis (HIV) - Scientists Report on Single Binding Site for the CD4 Receptor
Vectors (Anopheles gambiae) - Genetic Map May Help Molecular Genetic Studies of Malaria Vector
Phenylketonuria - "Gene Therapy for Phenylketonuria."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.